Drug for Uncontrollable Laughing and Crying is Moving toward European Licensing

Avanir continues to work with the European Medicines Agency to secure an accelerated review of their drug Nuedexta for the treatment of pseudobulbar affect. Nuedexta has already been approved for use in the US and if the EMA grants their approval, Nuedexta could reach patients in Europe during the first half of 2013.

Click here to read more.

Share this: